Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹347 Cr₹317 Cr₹261 Cr₹237 Cr₹60 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹347 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹347 Cr
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹347 Cr
9.22
Mar2025 ₹317 Cr
21.53
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹26,013.6 Cr 2.3% -5.4% 14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,589.0 Cr 1.4% 8.1% -6.8% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.3%

-5.4%

14.8%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses